Bureau Veritas SA
PAR:BVI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
21.44
30.64
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Bureau Veritas SA
Bureau Veritas SA
Other Liabilities
Bureau Veritas SA
Other Liabilities Peer Comparison
TEP
ALGEC
AAA
ASY
ALNLF
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bureau Veritas SA
PAR:BVI
|
Other Liabilities
€310m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
|
Teleperformance SE
PAR:TEP
|
Other Liabilities
€99m
|
CAGR 3-Years
46%
|
CAGR 5-Years
33%
|
CAGR 10-Years
27%
|
|
|
GECI International SA
PAR:ALGEC
|
Other Liabilities
€237k
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-2%
|
|
|
Alan Allman Associates SA
PAR:AAA
|
Other Liabilities
€15m
|
CAGR 3-Years
82%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Assystem SA
PAR:ASY
|
Other Liabilities
€27.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-1%
|
|
|
Neolife SA
PAR:ALNLF
|
Other Liabilities
€56.6k
|
CAGR 3-Years
4%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
See Also
What is Bureau Veritas SA's Other Liabilities?
Other Liabilities
310m
EUR
Based on the financial report for Jun 30, 2024, Bureau Veritas SA's Other Liabilities amounts to 310m EUR.
What is Bureau Veritas SA's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
3%
Over the last year, the Other Liabilities growth was 1%. The average annual Other Liabilities growth rates for Bureau Veritas SA have been -8% over the past three years , -5% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet
